Menu
Fechar
hrs4r
Quiero donar
Firma
JOAN BRUNET-VIDAL
Posición
Investigador/a Consolidat - R3
Investigador/a Consolidado - R3
Projectes
Publicacions

Projectes

Oncología de Precisión de Girona

Evaluación de un nuevo biomarcador pan-cáncer para mejorar la predicción de respuesta a inmunoterapia.

Codi oficial: biomarcador pan-cáncer Data inicio:19/10/2020 Data fi: 01/12/2025 Investigador/a principal: JOAN BRUNET VIDAL Organisme finançador: SOCIEDAD ESPAÑOLA DE ONCOLOGÍA MÉDICA (SEOM)
Oncología de Precisión de Girona

Data-driven cancer genome interpretation for personalised cancer treatment

Codi oficial: 101057509 Data inicio:01/11/2022 Data fi: 31/10/2027 Investigador/a principal: JOAN BRUNET VIDAL, JOAQUIM BOSCH BARRERA, RAMON BRUGADA TERRADELLAS Organisme finançador: EUROPEAN HEALTH AND DIGITAL EXECUTIVE AGENCY (HADEA)
Oncología de Precisión de Girona

CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

Codi oficial: 101095483 Data inicio:01/01/2023 Data fi: 30/06/2026 Investigador/a principal: JOAN BRUNET VIDAL Organisme finançador: EUROPEAN HEALTH AND DIGITAL EXECUTIVE AGENCY (HADEA)
Oncología de Precisión de Girona

Y-RNAs AS NON-INVASIVE BIOMARKERS FOR EARLY CANCER DETECTION

Codi oficial: IDEAS246813BRUN Data inicio:01/12/2024 Data fi: 30/11/2026 Investigador/a principal: JOAN BRUNET VIDAL Organisme finançador: ASSOCIACIÓ ESPANYOLA CONTRA EL CÀNCER
Oncología de Precisión de Girona

PRISMA-II: Estratificación del riesgo de cáncer de mama/ovario mediante incorporación del polygenic risk score. Validación en portadoras, cohorte prospectiva, y viabilidad de la secuenciación de genoma

Codi oficial: PI23/01047- PRISMA Data inicio:01/01/2024 Data fi: 31/12/2026 Investigador/a principal: JOAN BRUNET VIDAL Organisme finançador: INSTITUTO DE SALUD CARLOS III

Publicacions

Rofes, P, Castillo-Manzano, C, Menéndez, M, Teulé, A, Iglesias, S, Munté, E, Ramos-Muntada, M, Gómez, C, Tornero, E, Darder, E, Montes, E, Valle, L, Capellá, G, Pineda, M, Brunet, J, Feliubadaló, L, del Valle, J, Lázaro, C

<i>TP53</i> germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate

GENOME MEDICINE, 2025, 17, 3-3 dx.doi.org/10.1186/s13073-025-01429-5
Peremiquel-Trillas P, Martínez JM, Paytubi S, Frias-Gomez J, Pelegrina B, Marin F, Benavente Y, Ibáñez R, Barahona M, Fernandez-Gonzalez S, Cárdenas L, Taltavull A, Darder E, de Sanjosé S, Widschwendter M, Matias-Guiu X, Bosch X, Pineda M, Ponce J, Brunet J, Alemany L, Costas L

Acceptability and somatic mutations in cervicovaginal self-sampling for early endometrial cancer detection in women with Lynch syndrome.

INTERNATIONAL JOURNAL OF CANCER, 2025, 156, 1791-1801 dx.doi.org/10.1002/ijc.35368
López-Fernández A, Duran-Lozano L, Villacampa G, Pardo M, Pérez E, Darder E, Vallmajó A, Alfonso R, Cruellas M, Roqué A, Cartró M, Bareas A, Carrasco E, Rezqallah A, Jimenez-Macedo AR, Torres-Esquius S, Torres M, Lopez C, Espinosa M, Teulé A, Munté E, Tuset N, Diez O, Feliubadaló L, Lázaro C, Llort G, Carver T, Ficorella L, Mavaddat N, Mercadé A, Antoniou AC, Brunet J, Ramon Y Cajal T, Balmaña J

A randomized study of 2 risk assessment models for individualized breast cancer risk estimation.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025, 117, 1593-1604 dx.doi.org/10.1093/jnci/djaf067
Sánchez A, Castillo-Iturra J, Roos VH, Dueñas N, Pineda M, Moreno L, Rodriguez-Alonso L, Ramon Y Cajal T, Llort G, Piñol V, Lopez Fernandez A, Salces I, Pico MD, Rivas L, Bujanda L, Garzon M, Pizarro A, Martinez de Castro E, Lopez-Arias MJ, Poves C, Garau C, Rodriguez-Alcalde D, Herraiz M, Alvarez-Urrutia C, Dacal A, Carrillo-Palau M, Cid L, Ponce M, Barreiro-Alonso E, Saperas E, Aguirre E, Bastiaansen B, Ocaña T, Carballal S, Rivero-Sanchez L, Ortiz O, Daca-Alvarez M, Prat-Galito R, Bessa X, Cubiella J, Jover R, Rodríguez-Moranta F, Balmaña J, Brunet J, Castells A, Capellá G, Ladabaum U, Dekker E, Moreira L, Pellise M, Balaguer F

Gene-specific detection rate of adenomas and advanced adenomas in Lynch syndrome.

Gastroenterology, 2025, 169, 663-675 dx.doi.org/10.1053/j.gastro.2025.03.042
Hendricks LAJ, Verbeek KCJ, Schuurs-Hoeijmakers JHM, de Jong MM, Links TP, Brems H, Aerden M, Brunet J, Lleuger-Pujol R, Hüneburg R, Aretz S, Colas C, Villy MC, Woodward ER, Evans DG, Bosch DGM, Donze SH, Foretová L, Blatnik A, Leter EM, Tischkowitz M, Jahn A, de Putter R, Dupont J, Briskemyr S, Steinke-Lange V, Baldassarri M, Anastasiadou VC, Irmejs A, Oliveira C, van der Post RS, Mensenkamp AR, Tesi B, Mu N, Benusiglio PR, Gerasimenko A, Innella G, Turchetti D, Houdayer C, Branchaud M, Høberg-Vetti H, Haavind MT, Balmaña J, Torres M, Genuardi M, Panfili A, Jørgensen K, Mæhle L, Hoogerbrugge N, Vos JR

The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).

GENETICS IN MEDICINE, 2025, 27, 101467-101467 dx.doi.org/10.1016/j.gim.2025.101467
Hendricks LAJ, Verbeek KCJ, Schuurs-Hoeijmakers JHM, de Putter R, Brems H, Van Daele SH, Anastasiadou VC, Foretová L, Benusiglio PR, Gerasimenko A, Colas C, Villy MC, Houdayer C, Branchaud M, Hüneburg R, Aretz S, Jahn A, Steinke-Lange V, Innella G, Turchetti D, Barili V, Genuardi M, Panfili A, Baldassarri M, Irmejs A, de Jong MM, Links TP, Leter EM, Bosch DGM, Donze SH, van der Post RS, Mensenkamp AR, Westdorp H, Høberg-Vetti H, Tveit Haavind M, Jørgensen K, Mæhle L, Briskemyr S, Garcia JD, Blatnik A, Balmaña J, Torres M, Brunet J, Lleuger-Pujol R, Tham E, Tischkowitz M, Evans DG, Hyder Z, Hoogerbrugge N, Vos JR

Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study.

Bjc Reports, 2025, 3, 42-42 dx.doi.org/10.1038/s44276-025-00157-y
López-Fernández A, Pardo M, Pérez-Ballestero E, Darder E, Alfonso R, Torres-Esquius S, Navarro Garcés V, Ramón Y Cajal T, Brunet J, Balmaña J

Exploring communication preferences for disclosing breast cancer risk in women with a family history.

JOURNAL OF GENETIC COUNSELING, 2025, 34 dx.doi.org/10.1002/jgc4.70114
Salvador, L, del Valle, J, Dorca, E, Chong, AS, Chong, AL, Valenzuela, JC, Munté, E, Rioja, C, Martí-Sánchez, L, Salinas, M, Darder, E, Fabian, MR, Brunet, J, Salvador, H, Lázaro, C, Rivera, B

DICER1 in pediatric and adult cancer predisposition populations: Prevalence, phenotypes, and mosaicism

GENETICS IN MEDICINE, 2025, 27 dx.doi.org/10.1016/j.gim.2025.101385
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arun BK, Arver B, Bandera EV, Barile M, Barkardottir RB, Barrowdale D, Beckmann MW, Benitez J, Berchuck A, Bisogna M, Bjorge L, Blomqvist C, Blot W, Bogdanova N, Bojesen A, Bojesen SE, Bolla MK, Bonanni B, Børresen-Dale AL, Brauch H, Brennan P, Brenner H, Bruinsma F, Brunet J, Buhari SA, Burwinkel B, Butzow R, Buys SS, Cai Q, Caldes T, Campbell I, Cannioto R, Chang-Claude J, Chiquette J, Choi JY, Claes KBM, Cook LS, Cox A, Cramer DW, Cross SS, Cybulski C, Czene K, Daly MB, Damiola F, Dansonka-Mieszkowska A, Darabi H, Dennis J, Devilee P, Diez O, Doherty JA, Domchek SM, Dorfling CM, Dörk T, Dumont M, Ehrencrona H, Ejlertsen B, Ellis S, Engel C, Lee E, Evans DG, Fasching PA, Feliubadalo L, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Foretova L, Fostira F, Foulkes WD, Fridley BL, Friedman E, Frost D, Gambino G, Ganz PA, Garber J, García-Closas M, Gentry-Maharaj A, Ghoussaini M, Giles GG, Glasspool R, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Goode EL, Goodman MT, Greene MH, Gronwald J, Guénel P, Haiman CA, Hall P, Hallberg E, Hamann U, Hansen TVO, Harrington PA, Hartman M, Hassan N, Healey S, Heitz F, Herzog J, Høgdall E, Høgdall CK, Hogervorst FBL, Hollestelle A, Hopper JL, Hulick PJ, Huzarski T, Imyanitov EN, Isaacs C, Ito H, Jakubowska A, Janavicius R, Jensen A, John EM, Johnson N, Kabisch M, Kang D, Kapuscinski M, Karlan BY, Khan S, Kiemeney LA, Kjaer SK, Knight JA, Konstantopoulou I, Kosma VM, Kristensen V, Kupryjanczyk J, Kwong A, de la Hoya M, Laitman Y, Lambrechts D, Le N, De Leeneer K, Lester J, Levine DA, Li J, Lindblom A, Long J, Lophatananon A, Loud JT, Lu K, Lubinski J, Mannermaa A, Manoukian S, Le Marchand L, Margolin S, Marme F, Massuger LFAG, Matsuo K, Mazoyer S, McGuffog L, McLean C, McNeish I, Meindl A, Menon U, Mensenkamp AR, Milne RL, Montagna M, Moysich KB, Muir K, Mulligan AM, Nathanson KL, Ness RB, Neuhausen SL, Nevanlinna H, Nord S, Nussbaum RL, Odunsi K, Offit K, Olah E, Olopade OI, Olson JE, Olswold C, O'Malley D, Orlow I, Orr N, Osorio A, Park SK, Pearce CL, Pejovic T, Peterlongo P, Pfeiler G, Phelan CM, Poole EM, Pylkäs K, Radice P, Rantala J, Rashid MU, Rennert G, Rhenius V, Rhiem K, Risch HA, Rodriguez G, Rossing MA, Rudolph A, Salvesen HB, Sangrajrang S, Sawyer EJ, Schildkraut JM, Schmidt MK, Schmutzler RK, Sellers TA, Seynaeve C, Shah M, Shen CY, Shu XO, Sieh W, Singer CF, Sinilnikova OM, Slager S, Song H, Soucy P, Southey MC, Stenmark-Askmalm M, Stoppa-Lyonnet D, Sutter C, Swerdlow A, Tchatchou S, Teixeira MR, Teo SH, Terry KL, Terry MB, Thomassen M, Tibiletti MG, Tihomirova L, Tognazzo S, Toland AE, Tomlinson I, Torres D, Truong T, Tseng CC, Tung N, Tworoger SS, Vachon C, van den Ouweland AMW, van Doorn HC, van Rensburg EJ, Van't Veer LJ, Vanderstichele A, Vergote I, Vijai J, Wang Q, Wang-Gohrke S, Weitzel JN, Wentzensen N, Whittemore AS, Wildiers H, Winqvist R, Wu AH, Yannoukakos D, Yoon SY, Yu JC, Zheng W, Zheng Y, Khanna KK, Simard J, Monteiro AN, French JD, Couch FJ, Freedman ML, Easton DF, Dunning AM, Pharoah PD, Edwards SL, Chenevix-Trench G, Antoniou AC, Gayther SA

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

NATURE COMMUNICATIONS, 2025, 16, 8237-8237 dx.doi.org/10.1038/s41467-025-63507-x
Mur, P, Pozuelo, A, Tabernero, J, Albanell, J, Bellosillo, B, Bosch, F, Briones, J, Brunet, J, Colomer, D, Domènech, M, Fontanet, JM, Matias-Guiu, X, Salazar, R, Vivanco-Hidalgo, RM, Mollà, M, Moreno, L, Prat, A, Ribera, JM, Clèries, R, Guarga, A, Espinàs, JA, Borras, JM

Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospects

Clinical & Translational Oncology, 2025 dx.doi.org/10.1007/s12094-025-04022-9

Formulari de contacte

Conoce el IDIBGI!

 menu